These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1762818

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
    Varga G, Papp M, Scarpignato C.
    Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419
    [Abstract] [Full Text] [Related]

  • 23. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
    Lilius TO, Rauhala PV, Kambur O, Rossi SM, Väänänen AJ, Kalso EA.
    Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists.
    McNaull B, Trang T, Sutak M, Jhamandas K.
    Eur J Pharmacol; 2007 Apr 10; 560(2-3):132-41. PubMed ID: 17307158
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Involvement of supraspinal and spinal CCK receptors in the modulation of antinociception induced by cold water swimming stress in the mouse.
    Suh HW, Song DK, Kwon SH, Kim KW, Min BH, Kim YH.
    Neuropeptides; 1996 Aug 10; 30(4):379-84. PubMed ID: 8914865
    [Abstract] [Full Text] [Related]

  • 27. [The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
    Sakatani N, Inui A, Baba S.
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct 20; 65(10):1149-58. PubMed ID: 2591604
    [Abstract] [Full Text] [Related]

  • 28. The effects of the cholecystokinin antagonist, proglumide, on gonadotropin release in the rat.
    Vijayan E, McCann SM.
    Brain Res Bull; 1986 Apr 20; 16(4):533-6. PubMed ID: 3087585
    [Abstract] [Full Text] [Related]

  • 29. Puerperal blockade of cholecystokinin (CCK1) receptors disrupts maternal behavior in lactating rats.
    Miranda-Paiva CM, Nasello AG, Yim AJ, Felicio LF.
    J Mol Neurosci; 2002 Apr 20; 18(1-2):97-104. PubMed ID: 11931355
    [Abstract] [Full Text] [Related]

  • 30. Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates.
    Watkins LR, Kinscheck IB, Kaufman EF, Miller J, Frenk H, Mayer DJ.
    Brain Res; 1985 Feb 18; 327(1-2):181-90. PubMed ID: 3838691
    [Abstract] [Full Text] [Related]

  • 31. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C, Varga G, Dobronyi I, Papp M.
    Br J Pharmacol; 1989 Mar 18; 96(3):661-9. PubMed ID: 2470456
    [Abstract] [Full Text] [Related]

  • 32. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat.
    Friedrich AE, Gebhart GF.
    J Pharmacol Exp Ther; 2000 Feb 18; 292(2):538-44. PubMed ID: 10640290
    [Abstract] [Full Text] [Related]

  • 33. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla.
    Heinricher MM, McGaraughty S, Tortorici V.
    J Neurophysiol; 2001 Jan 18; 85(1):280-6. PubMed ID: 11152727
    [Abstract] [Full Text] [Related]

  • 34. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
    Sullivan AF, Hewett K, Dickenson AH.
    Brain Res; 1994 Oct 31; 662(1-2):141-7. PubMed ID: 7859067
    [Abstract] [Full Text] [Related]

  • 35. The effect of long-term administration of lorglumide (CR 1409) on rat pancreatic growth and enzyme composition.
    Takács T, Nagy I, Pap A, Varró V.
    Pancreas; 1990 Sep 31; 5(5):606-10. PubMed ID: 1700417
    [Abstract] [Full Text] [Related]

  • 36. Peripheral participation of cholecystokinin in the morphine-induced peripheral antinociceptive effect in non-diabetic and diabetic rats.
    Torres-López JE, Juárez-Rojop IE, Granados-Soto V, Diaz-Zagoya JC, Flores-Murrieta FJ, Ortíz-López JU, Cruz-Vera J.
    Neuropharmacology; 2007 Mar 31; 52(3):788-95. PubMed ID: 17157334
    [Abstract] [Full Text] [Related]

  • 37. Antispasmodic activity on the gallbladder of the mouse of CR 1409 (lorglumide) a potent antagonist of peripheral CCK.
    Makovec F, Bani M, Cereda R, Chistè R, Pacini MA, Revel L, Rovati LC.
    Pharmacol Res Commun; 1987 Jan 31; 19(1):41-51. PubMed ID: 3575382
    [Abstract] [Full Text] [Related]

  • 38. Effect of lorglumide (CR-1409) on pancreatic secretory and trophic response to caerulein in newborn rats.
    Papp M, Varga G, Folly G.
    Acta Physiol Hung; 1991 Jan 31; 78(1):61-7. PubMed ID: 1722380
    [Abstract] [Full Text] [Related]

  • 39. Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance.
    Milne B, Sutak M, Cahill CM, Jhamandas K.
    Br J Pharmacol; 2008 Dec 31; 155(8):1264-78. PubMed ID: 18806811
    [Abstract] [Full Text] [Related]

  • 40. Peripheral factors in the mediation of cholecystokinin-induced satiety as assessed by comparative potencies of cholecystokinin antagonists.
    Murphy RB, Smith GP, Schneider LH, Gibbs J.
    Peptides; 1992 Dec 31; 13(1):77-81. PubMed ID: 1620660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.